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Abstract. Investigating the signalling pathways that
regulate heart development is essential if stem cells
are to become an effective source of cardiomyocytes
that can be used for studying cardiac physiology and
pharmacology and eventually developing cell-based
therapies for heart repair. Here, we briefly describe
current understanding of heart development in verte-
brates and review the signalling pathways thought to
be involved in cardiomyogenesis in multiple species.
We discuss how this might be applied to stem cells
currently thought to have cardiomyogenic potential
by considering the factors relevant for each differ-
entiation step from the undifferentiated cell to
nascent mesoderm, cardiac progenitors and finally a
fully determined cardiomyocyte. We focus particular-
ly on how this is being applied to human embryonic
stem cells and provide recent examples from both our
own work and that of others.
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Introduction
Chronic heart diseases such as ischemia and hyper-
tensive heart failure are characterized by irreversible
lossofcardiomyocytes.Generallyacceptedparadigms
are that adult cardiomyocytes lack the ability to
regenerate the myocardium in part because prolifer-
ation slows down at the time of birth. Although after
birth cardiomyocytes do undergo some rounds of cell
division (in human dividing cells are stillfound up to 3
weeks after birth), the last round of cell division in
both human and mouse is actually incomplete. The
cells undergo nuclear division only, and as a result the
adultcardiomyocyteseitherhavetwodiploidnucleior
one tetraploid nucleus. In addition, the heart was
considered to lack stem cells. However, several recent
reports [1–3] have described resident stem cell pop-
ulations in human and rodent hearts that proliferate
and may give rise to cardiomyocytes, vascular smooth
muscle cells and endothelial cells.
Nevertheless, the regenerative capacity of the heart is
still limited, and cell transplantation for the treatment
of cardiac disease remains an attractive concept.
Finding the most suitable source of cells for this
purpose is, however, a major challenge of experimen-
tal cardiology at the present time. Stem cells may be
derived either from adult human tissues ( adult stem
cells ) or from human embryos ( embryonic stem
cells ). Both are considered as options deserving
further research, although there are ethical reserva-
tions on using human embryonic stem cells (HESCs)
because their derivation involves destruction of the
embryo (reviewed in [4, 5]). Here, we provide a brief
introduction to stem cells and the scientific back-
ground to current approaches to producing, selecting
and identifying the most suitable cells for restoring
cardiac function. Many of these are based on the
premise that understanding heart development will
lead to ways of (re) programming stem cells. The
recent literature has been confused by the question of
whether adult stem cells, particularly those derived
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Cellular and Molecular Life Sciencesfrom conventional hematopoietic sources like bone
marrow, or umbilical cord blood, can  transdifferen-
tiate i.e.converttoanotherlineagebydifferentiation.
The consensus is that bone marrow may have ther-
apeutic benefit but that this is not based on the ability
of bone marrow cells to transdifferentiate into car-
diomyocytes (reviewed in [6]). We will not consider
this in detail here. There are at present two or,
possibly, three stem cell sources of bona fide cardio-
myocytes: ESCs, resident cardiac progenitor or stem
cells in the heart (CPCs or CSCs) and possibly
mesenchymal stem cells (MSCs), present in bone
marrow, cord blood and adipose tissue. Most strat-
egies used involve inducing differentiation of stem
cellsinculturetoacardiacphenotypecompatiblewith
survival, electromechanical coupling and integration
in the host heart tissue, without causing arrythmias.
Adult cardiomyocytes do not survive transplantation
into the adult heart [7],and skeletal muscle myoblasts
are functionally isolated from their host cells, which
may lead to arrythmias [8]. However, fetal cardio-
myocytes from various species, including humans, do
survive transplantation in the heart [9, 10], so the goal
may be to derive cells with fetal cardiomyocyte
phenotype.
An important question is how to obtain these human
(fetal)cardiomyocytesinsufficientlylargenumbersto
beofuseintherapy.Inpractice,thismightmean~10
8–
10
9 cells being required for each adult patient, the
number of cardiomyocytes lost in the left ventricle
following a major myocardial infarction in humans.
Clearly, deriving them routinely from human fetuses
would raise important ethical issues. Alternatives
would be to identify and expand cardiac progenitors
with the capacity to proliferate ex vivo either from the
adult or fetal heart, or derive cardiomyocytes from
stemcellsathighefficiency.Fromtheadultheartthere
would be the advantage that the cells could be
autologous. For all strategies, understanding how
cardiac cell fate is specified by extracellular cues in
the embryo, what the molecular signatures are of the
intermediate differentiation states of the cardiomyo-
genic lineage and how the electrical and physiological
phenotypes of stem cell-derived cardiomyocytescom-
pare with those ofthe normal counterparts isessential
if cell transplantation therapy is to be used effectively
in restoring cardiac function.
Recapitulating the extracellular signals used by the
embryo to drive differentiation is currently proving
themostfruitfulstrategytocontrolthedifferentiation
of stem cells to selected lineages [11, 12]. By contrast,
ectopic expression of lineage-associated or -specific
transcription factors has met with relatively little
success even in mESCs; it appears that signal timing,
duration and dose are much more subtle than can be
achieved by the relatively crude method of gene
overexpression. Here we consider possible stem cell
sources of cardiomyocytes for cardiac repair, review
thesignalsthoughttocontrolallocationofpluripotent
cells first to the nascent mesoderm lineages during
gastrulation, then their subsequent development into
cardiac progenitors and fully differentiated cardio-
myocytes (Fig. 1). We begin, however, with a short
description of heart development in mammals.
Differentiation and early morphogenesis in the
mammalian heart
Heart formation is initiated in vertebrate embryos
soon after gastrulation when the three embryonic
germ layers, ectoderm, endoderm and mesoderm, are
established in the primitive streak. The heart is
derived from the mesoderm and is the first definitive
organ to form in development. Its morphogenesis,
growth and integrated function are essential for
survival of the embryo even by midgestation. Cardiac
progenitor cells are for the most part localized in the
anterior primitive streak. Different populations of
precursor cells are distributed within the streak (in
relation to the organizing centre, or node) in the same
anterior-posterior order that they are later found in
the tubular heart [13]. As a result, cells furthest from
the node end up in the atrium, those nearer the node
end up in the ventricle whilst those nearest the node
later form the outflow tract. In addition to precursors
in the primitive streak, there are also precursors
bilaterally distributed in the epiblast directly adjacent
tothestreak.Asdevelopmentproceeds,theprecursor
population of precardiac mesoderm emigrates from
the streak in an antero-lateral direction, giving rise to
the heart-forming fields on either side of the streak.
These heart fields formed at gastrulation give rise to
the left ventricle and possibly the atrioventricular
canal (AVC) and part of the atria as well as endocar-
dial progenitor cells. During subsequent development
the right ventricle and outflow tract are added from
the anterior heart field and the inflow tract from the
posterior heart field. The expression of Islet-1 defines
two cell populations of which one generates the linear
heart tube, i.e. the left ventricle, and the other
contributes to the rest of the developing organ [14].
The axial distribution is maintained as the fields
migrate to fuse and form the cardiac crescent. Cells of
the cardiac crescent then adopt a definitive cardiac
fate in response to cues from adjacent anterior
endoderm [15]. Anterior endoderm in particular
appears to have an instructive function in cardio-
genesis in various species (reviewed in [16]). Ablation
of anterior endoderm in amphibians results in loss of
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posterior, blood-forming mesoderm in chick are
reprogrammed to express cardiac instead of blood-
restricted marker genes if combined with anterior
endoderm [18]. After cardiac mesoderm has been
specified, it ends up at the ventral side of the embryo
where the heart field start to fuse due to folding of the
embryo. A single heart tube thus forms. In mutant
mouse and zebrafish in which this fails to take place,
two tube-like structures form (cardiac bifida) which
both acquire contractile activity [19-22]. However, in
the GATA4 and miles-apart knockouts the pheno-
types are due to folding defects, the heart abnormal-
ities in these cases being secondary events. Some
mutantsalso lackor have defective endodermal tissue
[22]. Thus, the endoderm is not only important for
differentiation of cardiac precursors but is also
essential for cardiac mesoderm migration, although
it is clear that tube formation also involves a cell
autonomous function of cardiac mesoderm itself.
Once this process of primary cardiac induction is
complete, cells are then recruited from lateral plate
mesoderm, medial to the primary heart field, to give
rise to the secondary, anterior heart field (AHF). The
cells recruited contribute to the primitive right
ventricle and outflow tract [23]. Whilst the heart
tube is initially almost straight, the ventricular seg-
ment at this stage starts to bulge ventrally, flips to the
right and begins to form a C-shaped heart. Left-right
asymmetry thus becomes evident and cardiac looping
Figure 1. A modelof embryonicstemcell differentiation towardsthe cardiomyocyte lineagebasedon currentmouseESC differentiation
methods. Pluripotent ESCs are maintained through transcription factors Oct-4, Nanog and Sox-2. Given appropriate signals from EB
culture or a 2D culture system, the cells differentiate into a primitive, pre-hemangioblast type cell with broad mesodermal potential (blue
arrow). These cells are characterised by the expression of key transcription factors like brachyury and MESP and may still retain the
expression of pluripotency associated genes. From these cells, a Flk-1-positive subpopulation appears with hemangiblast-like
differentiation activity highlighted by a robust ability to form blood cells (large orange arrow). However, these cells still retain
remarkable plasticity and can give rise to increasingly more restricted Flk-1-positive progenitors (blue arrow). More restricted Flk-1-
positive cells may predominantly differentiate into endothelial cells (large orange arrow) and less readily (small orange arrow) to cardiac
cells. Immunosorting or magnetic cell separation for Flk-1 and other surface receptors like CXCR4 enables the enrichment of a more
definedprogenitorcellsubpopulationwhichdifferentiatespredominantlyintobeatingcardiomyocytes(largeorangearrow)withalimited
capacity to form endothelial cells (small orange arrow).
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 ballooning  steps and morphogenetic movements the
four-chambered heart eventually forms [24].
Embryonic and adult stem cells
Stem cells are primitive cells present in all organisms
that can divide and give rise to more stem cells or
switch to become more specialized cells, such as those
of heart, brain, muscle and kidney. Stem cells in early
embryos give rise to cells of all tissues of the adult
body and are therefore termed pluripotent. Stem cells
of adult tissues, involved in tissue replacement and
repair, usually give rise only to cell types already
presentinthesurrounding tissuesfromwhichtheyare
derived. Restricted differentiation and inability to
crosslineageboundarieshasledtothembeingtermed
multipotent. Stem cells of the bone marrow, for
example, give rise to hematopoietic cells.
The first ESCs were isolated 25 years ago from mouse
preimplantation embryos 3.5 days after fertilization.
The background to the discovery lay in the study of
teratocarcinoma,aspontaneoustumourofthetestisin
mice and humans, consisting of tissues as diverse as
hair,muscle,boneandevencompleteteethaswellasa
stem cell population.
Teratocarcinomas also containing stem cells or em-
bryonal carcinoma (EC) cells were found to be
induced in mice by transferring embryos to extra-
uterine sites. EC cells could be isolated and grown in
culture without losing the capacity to differentiate.
This was most strikingly demonstrated by introducing
them into embryos where they were able to form
chimaeras and contribute to all somatic tissues. These
studies were followed by attempts to isolate stem cells
directly from mouse embryos, without an intermedi-
ate teratocarcinoma stage. In 1981, two groups
succeeded in establishing mouse ESC lines [25, 26].
In view of the similarities between mouse and human
teratocarcinomasandtheirspontaneousoccurrencein
the testis, it was predicted that ESCs could be isolated
from human embryos. The motivation initially was for
studyingearlyhumandevelopment,butlaterperspec-
tives for cell transplantation therapies became evi-
dent. In 1998 the first HESCs were derived from
blastocysts surplus to requirements for assisted repro-
duction. The markers developed by pathologists to
diagnoseECcellsinhumantumoursprovidedthefirst
evidence of their undifferentiated phenotype; their
capacity to form teratocarcinomas containing many
tissue types in immunodeficient mice confirmed their
pluripotency [27].
A second group described the isolation of two HESC
linesindependentlysoonafter[28].Sincethen,almost
400 HESC lines have been derived worldwide, many
of which are now being collectively characterized in a
largeinternationalconsortium[29].Inaddition,many
publications have described their differentiation to
various cell types in culture in response to cytokines,
hormones and growth conditions. These include
neural cells (neurons, glia and oligodendrocytes),
vascular endothelial cells, insulin-producing pancreas
cells, cartilage and bone, cardiomyocytes, hemato-
poietic cells and hepatocytes (reviewed in [30]).
HESC differentiation to cardiomyocytes
The first report of cardiomyocyte differentiation [31]
appeared almost 3 years after HESCs were first
derived. To induce cardiomyogenesis, cells were
dispersed into small clumps of 3–20 cells and grown
for 7–10 days in suspension to form structures like
embryoid bodies (EBs) from mESCs. This approach
was based on that developed in the 1990s for mESCs
bythegroupsofDoetschmanandWobus(reviewedin
[4]). After plating onto culture dishes, beating areas
wereobservedin~8%oftheoutgrowths20dayslater.
Thisspontaneousdifferentiationtocardiomyocytesin
HESC aggregates was also observed by others [32],
but in this case approximately 25% of the EBs were
beatingafter8daysofdifferentiationand70%after20
days. Other reports described spontaneous differ-
entiation of cardiomyocytes from HESCs, with 10–
25% of the embryoid bodies beating after several
weeks [33]. The reasons for these differences in
efficiency are not clear, but cell lines appear to differ
and counting beating EBs may not accurately reflect
the conversion of HESC to cardiomyocytes; variable
numbersofcardiaccellsandnon-cardiomyocytesmay
be present. An alternative differentiation method is
based on co-culture of HESC with a visceral endo-
derm-like cell line (END-2) or growth of HESC EBs
in END-2 conditioned medium [34, 35]. Since (vis-
ceral) endoderm plays an important role in the
differentiation of cardiogenic precursor cells in the
adjacent mesoderm in vivo during development, the
underlying molecular mechanism may reflect that
occurringintheembryo.Allofthesemethodsresultin
conversion of HESCs to cardiomyocytes at relatively
low efficiencies however, illustrating the possible
benefits to be derived from a better understanding
of the stepwise process of cardiac development.
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Theprocessofformingaheartinadevelopingembryo
requiresmanysignals,someofwhichoriginateoutside
the pre-cardiac mesoderm and some of which origi-
nate in the developing heart. The fruitfly Drosophila
melanogaster has been a major source of insights into
the molecular control of heart development. Three
mainfamiliesofpeptidegrowthfactorshavethusbeen
identified as being essential for heart development,
and all have proved to be of similar importance in
heart development in mammals, both as positive and
negative regulators. These are the bone morphoge-
netic proteins (BMPs), members of the transforming
growth factor b superfamily, the Wnts and the
fibroblast growth factors (FGFs). Members of all of
these families or their inhibitors are expressed in
endoderm. Disrupted expression of these ligands,
receptors or their downstream target genes has
dramatic and distinct effects on cardiac development
that are highly conserved between species (reviewed
in [36]). BMPs control several major cardiac specific
transcription factors, including Nkx 2-5, the mamma-
lian homologue of tinman, through SMAD binding
sites [16, 37, 38]. BMP2, 4 and 7 are co-expressed
spatially and temporally with GATA-4 and Nkx 2-5 in
the pre-cardiac mesoderm, again suggesting they may
control the expression of cardiac transcription factors
[39, 40]. As in Drosophila, treatment of mammalian
embryoswithBMPresultsintheectopicexpressionof
Nkx 2-5 and GATA-4 [39]. The addition of noggin, a
BMP antagonist, to developing embryos inhibits
differentiation of cardiac cells [39, 41]. Mouse
BMP2
–/– mutants have abnormal heart development,
butheartprecursorsdevelopnormally,suggestingthat
BMP2 is not required for the induction of cardiomyo-
cytes, but for their subsequent organization [42].
BMP2isalsoexpressedinendoderm,atissueadjacent
to the heart-forming region and containing the most
cardiac inductive activity [39]. BMP5 and 7 double
knockout mice have severely delayed cardiac mor-
phogenesis [43]. In general, therefore, BMP signaling
appears to promote cardiogenesis in vertebrates [39,
44–48] and is also required to generate mesoderm/
cardiac muscle cells from mouse EC cells and ESCs in
culture [49].
Wingless in Drosophila and related Wnt proteins in
vertebrates are involved in cardiac specification,
although their function in mammals is complex.
Wnts were initially considered suppressive of heart
formation, but both induction and inhibition have
sincebeenreported.The canonical Wnts1,3Aand8,
acting by inhibition of GSK3 allowing nuclear local-
ization of b-catenin, appear to inhibit cardiac differ-
entiation, whereas the non-canonical Wnt 11, involv-
ing protein kinase C, seems to enhance cardiac
differentiation (reviewed in [36]). Supporting this,
inhibition of the canonical Wnt signaling increases
cardiac differentiation [50], and conditional deletion
of b-catenin from the definitive endoderm of the
mouse results in the formation of multiple ectopic
hearts [51]. The presence of crescent, dkk-1 or other
Wnt antagonists induces cardiomyocyte differentia-
tion in non-heart-producing mesoderm [50, 52, 53].
Wnts 3A and 8 block Nkx 2-5 and Tbx expression and
therefore cardiomyocyte differentiation [50]. How-
ever, in contrast to these findings Wnt3A and Wnt8
were found to promote cardiac differentiation in
P19Cl6 cells, a clonal line derived form P19 EC cells
[54]. The complexity of this matter is discussed in
detail by Olson and Schneider [36]. Recent findings
showing that b-catenin signaling must be blocked for
heart valve formation in zebrafish also demonstrate a
negativeroleforWntsinthedevelopmentoftheheart
[55]. We recently observed a similar negative effect of
canonical Wnt-signalling on cardiac differentiation in
the HESC-END-2 co-culture system. BIO, a small
molecular activator of canonical Wnt signaling, in-
hibitednotonlythenumberofbeatingaggregatesthat
form in the cultures but also reduced cardiac marker
expression at the protein and RNA levels (Fig. 2).
Wnt 11, a non-canonical Wnt, can by contrast induce
cardiomyogenesis in the non-precardiac mesoderm of
chickembryos[56].Thismaybearesultofitsabilityto
block canonical Wnt signaling by sequestering cyto-
plasmic b-catenin and inducing cardiomyogenesis.
Results have not yet been reconciled but may relate
to distinct effects of the canonical (acting via b-
catenin/GSK3 to repress cardiogenesis) versus non-
canonical (acting via PKC/JNK to promote cardio-
genesis) signaling pathways, and/or indirect effects in
certain model systems (e.g., induction, expansion or
augmentation of BMP-producing endoderm-like
cells). The state of the cells at the time of receiving
the signal combined with the presence of specific
cofactors may determine the ultimate biological
response.
Finally, some limited studies in chick and zebrafish
have implicated a cardioinductive role for FGFs [57–
59], although in Drosophila, the functions of FGFs in
heart development have been investigated in more
detail because of the availability of specific mutants.
Drosophila has only two FGFreceptors, and only one
of them, heartless (htl), is expressed in the mesoderm
in early gastrulation and during differentiation; it is
required for normal cardiac development [60–62]. Htl
mutants have no dorsal vessel, the cardiac organ in
Drosophila [60]. This is probably due in part to a role
in directing the migration of cardiac precursors in the
mesoderm (reviewed in [60]). However,in addition to
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differentiation,HES2cellswereco-culturedwithEND2 feeders[35]andculturedinaserum-freemediumforatleast12days[108].Atday
5, the medium was changed, and BIO was added at a concentration of 1 or 2 mM in serum-free medium (or serum-free medium only, for
control). At day 9 and 12, the co-cultures were refreshed with serum-free medium only, then harvested for RNA or protein isolation. (a)
Scoringofthenumberofareasofbeatingmusclein theco-culturesatday12showedthatBIOwasinhibitory. Onaverage,thereductionin
thenumberofbeatingareaswas18-foldinthepresenceof1 mMBIOand61-foldinthepresenceof2 mMBIO,respectively,comparedwith
controlvalues.(b)Determiningtheexpressionoftwocardiacproteins,a-actininandbMHC,byreal-timepolymerasechainreaction(PCR)
showed a reduction in the presence of BIO addition by 10- and 11- fold, respectively, in the presence of 1 mM BIO and 164- and 93-fold,
respectively, in the presence of 2 mM BIO. The cycle number at which the reaction crossed an arbitrary threshold (Ct) was determined for
each gene. The relative number of messenger RNA levels was determined by 2-DCt. Relative gene expression was normalized to hARP
expression.(c) Analysisofthe effectofBIO on cardiacdifferentiationin 17-dayco-culturesby Westernblottingshowed a strongdecrease
in the expression of the cardiac marker tropomyosin in the presence of BIO. p values were determined using the Man-Whitney test.
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direct role in cardiomyogenic specification; blocking
htl function after migration has occurred also blocks
cardiac precursor specification [62].
There are multiple FGF family members in verte-
brates, although not all have been implicated in heart
development. FGFs 1, 2 and 4 have been identified as
being secreted by the portion of the developing
embryo that is necessary for cardiac development,
although their exact role is unclear. What is clear is
that they cooperate with BMPs to induce cardiomyo-
genesis [58]. In chick embryos, FGF2 and 4 induce
cardiomyogenesis in non-precardiac mesoderm, but
thedifferentiationismuchmoreefficientifBMP2or4
is also present [58, 63]. Another family member,
FGF8, is expressed in the cardiac mesoderm of mice,
chicksandzebrafish[59,64,65].Again,BMPsseemto
cooperate with FGF8 in heart induction and morpho-
genesis, BMP2 upregulating FGF8 in chick embryos
[59] and synergizing to drive mesodermal cells into
myocardial differentiation. Zebrafish with FGF8
mutations do not express Nkx 2-5 or GATA-4 in the
precardiac mesoderm and have severely deformed
ventricles [65]. This may be directly or indirectly due
tothefactthatthesemutantzebrafishhavelessNkx2-
5 and GATA-4 expression [65]. These three signalling
pathways activatedbyBMP,WntandFGFligandsare
essential not only for primary cardiogenesis but are
also involved in secondary (AHF) cardiogenesis
(reviewed in [16]).
Once anterior mesoderm cells have received appropri-
ate signals, such as those described above, they switch
on a set of cardiac-restricted transcription factors that
interactincombinationtocontroldownstreamgenesin
the cardiac pathway. The homeodomain transcription
factor Nkx2.5 [66] and the T-box protein Tbx5 [67, 68]
are among the earliest markers of the cardiac lineage
and are activated shortly after cells have formed the
heart fields. Nkx2.5 is thought to be required in mice
specifically for left ventricular chamber development
[69], whilst loss of Tbx5 results in severe hypoplasia of
both the atrial and left ventricular compartments [70]
and may thus be important for the formation of both.
Nkx2.5andTbx5associatewithmembersoftheGATA
family of zinc finger transcription factors and with
serum response factor (SRF) to activate cardiac
structural genes such as actin, myosin light chain
(MLC), myosin heavy chain (MHC), troponins and
desmin. Tbx5 can also cooperate with Nkx2.5 to
activate expression of ANFand the junctional protein
connexin 40 [70,71]. Members of the myocyte enhanc-
er factor 2 (MEF2) family of transcription factors also
play key roles in cardiomyocyte differentiation by
switching on cardiac muscle structural genes. In addi-
tion, association of SRF with a nuclear protein
myocardin activates cardiac specific promoters [72].
Thusmultiplecomplexinteractionstakeplacebetween
various transcription factors to control initial differ-
entiation and maturation of cardiomyocytes. Apart
from their functional role, many of these factors serve
as excellent markers of cardiomyocytes in differentiat-
ingculturesofhESCandmEScellsandcanbeusefulin
identifying the degree of maturity of specific cardiac
cells and the kinetics with which differentiation is
taking place because their normal expression is under
tight temporal control. A recent addition to this list is
Isl1, a LIM homeodomain transcription factor, which
identifies a cardiac progenitor population, including
cellsoftheanteriorheartfield,thatproliferatespriorto
differentiation and contributes the majority of cells to
the heart [14]. Unlike skeletal muscle cells, where
differentiation and proliferation are mutually exclu-
sive, embryonic cardiomyocytes differentiate and as-
semble sarcomeres even while they proliferate, al-
though organization is much greater postnatally. The
prospect of using Isl1 as a marker for the undiffer-
entiated cardiac progenitor state is exciting, and cell
sorting of differentiating hESC on the basis of Isl1
expression could allow further characterization and
expansion in culture [3]. This could provide a very
useful contribution to upscaling cardiomyocyte pro-
duction for transplantation.
Characteristics of ESC-derived cardiomyocytes
Fetal, neonatal, mouse ESC(mESC)-derived cardio-
myocytes and skeletal myoblasts have been shown to
engraft in the myocardium (reviewed in [73]), al-
though in the case of mESC-derived cardiomyocytes,
survival after transplantation to an infarcted mouse
heart has been problematic [74]. Thus, although
functional cardiomyocytes can easily be identified in
vitro by their beating phenotype, only more detailed
interrogation can establish the identity of the specific
cardiac cell types generated, their degree of maturity
comparedwithcardiomyocytesdevelopinginvivoand
whether they possess fully functional excitation-con-
traction coupling machinery that responds appropri-
ately to pharmacological agents.
As discussed earlier, differentiation of human HESCs
to the cardiac lineage creates a characteristic gene
expression profile [75] reminiscent of both mESC
differentiation and the early stages of normal mouse
heart development [76]. Analysis of RNA and pro-
teins from HESC-derived cardiomyocytes (HESC-
CMs) has demonstrated the presence of cardiac
transcription factors, including GATA-4, myocyte
enhancer factor (MEF-2) and Nkx2 transcription
factor-related locus 5 (Nkx2.5) [31, 32].
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fibers are appropriately expressed. These include a-,
b- and sarcomeric-myosin heavy chain (MHC), atrial
and ventricular forms of myosin light chain (MLC-2a
and-2v),tropomyosin,a-actininanddesmin,although
in contrast to mouse, heart chamber-restricted ex-
pression of structural proteins is less well defined in
humanheart,MLC-2v,forexample,isrestrictedtothe
ventricle in mouse and human fetal hearts but MLC-
2aisexpressedinbothatriumandventricleinhumans
and not just in atria as in mice [77]. This implies that
usingprotein orgeneexpression profilestodetermine
the phenotype of HESC-CMs in culture should be
done with caution. Antibody reactivity to two mem-
bers of the troponin complex, cardiac troponin T
(cTnT), which binds to tropomyosin, and cardiac
troponin I (cTnI), which provides a calcium-sensitive
molecular switch for regulation of striated muscle
contraction, has been demonstrated. cTnI appears to
be truly cardiac specific, as antibodies to this protein
only react with cells arising from beating and not non-
beating regions. In addition, upregulation of atrial
natriuretic factor (ANF), a hormone expressed in
both atrial and ventricular cardiomyocytes in the
developing heart, has also been observed during
cardiac differentiation of HESCs. Moreover, these
cells express creatine kinase-MB (CK-MB) and
myoglobin [32]. Thus, many of the transcription
factors, structural proteins and metabolic regulators
of cardiac development are found within HESC-CMs,
although they also react with antibodies to smooth
muscle actin, a protein found in embryonic and fetal,
but not adult cardiomyocytes, suggesting a limited
degree of maturation [32]. Single HESC cardiomyo-
cytesdisplayvariousmorphologies incultureandmay
be spindle-shaped, round, tri- or multi-angular, rather
than the rod shape of mature cells; sarcomeric
immunostaining shows striations in separated bun-
dles,ratherthanthehighlyorganizedparallelbundles,
as in human adult cardiomyocytes; and the action
potentials determined by patch-clamp electrophysiol-
ogy show ventricular phenotypes with upstroke veloc-
ities ~10 times lower than those of adult cardiomyo-
cytes [33, 35]. It is of interest to note that not only are
HESC-CMs connected to each other by connexin-43
expressing gap junctions [33], they are also capable of
forming de novo gap junctions with primary human
cardiomyocytes. In HESC-CMs co-cultured with pri-
maryhumanfetalcardiomyocytes,injectionofthedye
 Lucifer Yellow  into the HESC-CMs results in rapid
transfer of the dye via gap junctions, into the under-
lying primary cardiomyocytes [78]. This ability to
couplewithprimarycardiomyocyteswasnotobserved
in skeletal myoblasts. Despite their immaturity,
HESC-CMs may be useful in understanding the
activity of some pharmacological agents in (adult)
humancardiomyocytes,e.g.theL-typeCa
2+channelis
inhibited by verapramil, indicating that it is already
coupled to downstream signalling pathways, as in
postnatal cardiomyocytes but in contrast to mESC-
CM.
Because of their immaturity, they may be an excellent
source of cells for transplantation in terms of their
ability to survive and integrate [79, 80], and matura-
tion may take place in situ in the heart. For other
purposes, such as the studying the physiological
changes associated with genetic or degenerative
disease in the adult heart, mature human cardiomyo-
cytes may be required. Among the possibilities for
achieving this in culture is prolonged culture or cyclic
stretch or electrical stimulation. HESCs can provide
useful information on the molecular mechanisms
controlling early differentiation in the human heart.
Analysis of gene expression by microarray during
HESC-CM differentiation [75] showed that apart
from identifying most known cardiac transcription
factors, such as MEF2C, TBX2 and TBX5 and genes
encoding structural proteins, we observed upregula-
tion of multiple known genes not previously associ-
ated with cardiac development and several unexpect-
ed genes enriched or even uniquely expressed in the
heart. Some of these are conserved across species and
showrestrictedexpressionpatternsinbothmouseand
human fetal heart; further analysis by deletion in the
mouse should shed light on the function for these
genes, not only in mice but also in relation to
congenital heart defects in humans. This reflects a
more general strategy using HESCs for functional
analysis and gene mining in human development.
Resident cardiac stem cells and  bar codes  for the
mesoderm and cardiac lineage
It is clear that establishing the molecular identity of
the cellular intermediates and the signalling receptors
theyexpresswouldalsocontributetowardsoptimizing
each of the individual differentiation events and
therefore to the overall efficiency of converting stem
or progenitor cells into cardiomyocytes. This is of
particular relevance when adding growth factors or
small molecular agonists or antagonists to the specific
pathways now identified as being important in heart
development and specification. Several studies in
mESCs have now used particular cell surface proteins
and transcription factors as markers to separate cells
with different phenotypes at selected, early stages of
differentiation. This appears to facilitate enrichment
for particular cell types and has been most effectively
used for the mesodermal lineage, which gives rise to
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approaches to HESCs could result in significant
improvements in the efficiency of stem cell to
cardiomyocyte conversion. It is possible that the
transient cardiac progenitor stage through which
ESCs pass during differentiation to cardiomyocytes
is similar to that of resident CPCs or CSCs in the fetal
or adult heart, although the distinction between CPCs
and CSCs is not entirely clear. They may represent
differentstagesofthesametypeofcellorbesubsetsof
a more broadly defined cell population in the heart
(reviewed in [6]). They have often been selected on
the basis of general features of stem cells from other
tissues, such as cell surface markers or specific
biochemical properties, for example, the ability to
efflux Hoechst dye [81]. Cell surface markers, how-
ever, are of particular interest since fluorescent or
magnetic sorting based on a cell surface antibody
binding would be useful for selecting CPCs/CSCs or
cardiomyocytes for transplantation from primary
tissue or possibly differentiating HESC cultures.
Although few suitable cell surface protein-antibody
combinationshavebeenidentifiedforthesecelltypes,
their potential usefulness in enriching mixed cell
populations for particular cell subsets is becoming
clear.Inthefollowingsection,cellsurfaceproteinsare
discussed in the context of analysis of gene function in
heart development in mice.
Cell surface proteins and the isolation of progenitor
cells from the heart or ESCs
The generation of cell subpopulations with cardiac
differentiation potential has largely been based on
segregating cells which express receptors thought to
be involved in promoting the cardiogenic lineage
within the embryo.
Extracellular signalling molecules pivotal to cardiac
development were exemplified by gene knockout and
conditionaltargetingofgenesinmice.Developmental
cardiac phenotypes were observed in myocardial
specific knockouts of the receptor binding signalling
molecule for vascular endothelial growth factor
(VEGF), Vegfa, the BMP receptor Bmpr1a (or
ALK3) and the FGF receptors Fgfr1/Fgfr2.T h e
cardiomyocyte specific deletion of Fgfr1/Fgfr2 and
the global deletion of its ligand Fgf9 result in reduced
cardiac myocyte proliferation and abnormal myocar-
dial development. These findings indicate a role for
FGFs in maintaining the cell cycle progression of the
cardiomyocyte population in the developing heart.
The cardiomyocyte-restricted knockout of Vegfa re-
sults in coronary vascular deficiency and myocardial
thinning [82–84]. This suggests that the initiation of
myocardialcompactzonethickeningandthedevelop-
ment of coronary vasculature, two processes that
begin at E11-12 of mouse development, occur in a
coupled manner and may involve VEGF-A signalling
[85], although this has not been shown directly. There
is, however, clearly an interaction between the epi-
cardial and myocardial cells.
Lineage tracing studies in the mouse show that the
endocardium and a myocardial cell subpopulation
develop from a common lineage precursor that
expresses the VEGF-A ligand binding receptor, Flk-
1. Also termed VEGFR-2 (vascular endothelial
growth factor receptor-2), this is the major signalling
receptorforVEGF-A.Flk-1wasshowntobeessential
for the development of the vascular and hematopoiet-
ic lineages in the early embryo and to control blood
vessel formation [86, 87].
Unlike hematopoietic differentiation in the mESC
cell system, little progress has been made in identify-
ingandcharacterizingearly-stagecardiacprogenitors.
Using mESCs as a model, Keller and co-workers [89]
examined the developmental significance of Flk-1
receptorexpressionbydifferentiatingthecellsasEBs.
All cardiac tissue types were thus derived, and gene
expression analyses showed that formation of con-
tracting cardiac cells in EBs recapitulates cardiogen-
esis in the mouse embryo. As early as day 2.5–3.0 EBs
containedprehemangioblastmesoderm,evidencedby
cells positive for green fluorescent protein (GFP),
targeted to the Brachyury (Bry) locus [88, 89].
Brachyury is the founding member of the T box
family of transcription factors. It is expressed in all
nascentmesodermandisdownregulated asthesecells
undergo patterning and specification into derivative
tissues [90]. Day 3.25 Bry-GFP
+ cells from EBs,
immunosorted for the presence or absence of Flk-1
receptor,wereallowedtoreaggregateandattachonto
gelatin-coated plates for 3 days. The Flk-1
– subpopu-
lation generated adherent clumps which began rhyth-
mically contracting within 2–3 days. The cardiomyo-
cyte phenotype of these cells was confirmed by
positivestainingwithantibodiestotroponin-Tprotein
and cardiac transcription factors (Nkx2.5 and cMhc).
Immediately after isolation, Flk-1
+ cells only ex-
pressed hematopoietic transcription factors (Runx1
and Scl) and later markers indicative of maturation
along this lineage (Gata-1)[ 8 8 ].
The developmental potential of Bry-GFP
+ Flk-1
- cells
was investigated further by isolating these cells at
different stages of EB differentiation. Interestingly,
cells from days 2.5 and 3.0 generated a distinct Flk-1
subpopulation expressing high levels of the receptor.
Cells isolated from days 3.5 and 4.0 produced fewer
Flk-1
+ cells expressing low levels of the receptor.
Upon reaggregation, day 2.5 and 3.0 cells differ-
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cell types. Ten percent of day 3.0 reaggregates also
produced beating cardiomyocytes, and this increased
to 50% from cells isolated at day 3.5. None of the day
4.0cellaggregatesgeneratedbeatingstructures.These
data support the interpretation that hemangioblast
and cardiomyocyte cell lineages derive from distinct
mesodermal cell subpopulations present at different
time points of EB maturation. Both subpopulations
are marked by the emergence of Flk-1
+ cells; the
contribution of the Flk-1
lowcell subpopulation at day
3.0–3.5 to the production of the cardiac lineage from
EBs requires further investigation [88]. The potential
for cardiac differentiation in cultured EBs appears to
be restricted to a narrow time window present for 12–
18 hours from day 3.0 after aggregation onwards. The
sequential appearance of cells with hemangioblast
and cardiac fates within EBs in a defined kinetic
pattern recapitulates the temporal specification of
these populations in vivo [91]. Furthermore, the EB
environment was shown to inhibit the maturation of
cardiacprogenitorspresentatday3.5sincetheplating
of unsorted cells generated less than 1% beating
cardiomyocytes [88]. The above observations high-
light the importance of isolating specific progenitor
subpopulations from EB cultures on the basis of
intracellular and/or cell surface markers at early
stages of differentiation to maximize cardiac cell
differentiation (Fig. 1).
The appearance of a mESC-derived subpopulation,
positive for Flk-1 which differentiates into beating
cardiomyocytes, was also reported using a 2D culture
system [92–94]. Here, ESCs were plated onto type IV
collagen-coated dishes in the absence of leukemia
inhibitory factor (LIF) to allow differentiation. Nine-
ty-six to 108 h later Flk-1
+ cells that had developed
were purified by flow cytometric sorting and cultured
on a monolayer of OP9 stroma cells, a cell line
established from the calvaria of op/op mice. This
resulted in spontaneous beating of isolated Flk-1
+
cells. Neither paraformaldehyde-fixed OP9 cells nor
their conditioned medium induced beating,indicating
that direct contact was required for cardiomyocyte
differentiation. Like the END-2 visceral endoderm-
like cells discussed above, which effectively promote
cardiac differentiation of some HESC lines, the OP9
cells may provide signals similar to endoderm under-
lying cardiac mesoderm that is critical for the for-
mation of cardiac cells in the embryo [94].
The isolated Flk-1
+ cell subpopulation differentiated
into beating cells within 4–5 days of culture on OP9
stroma cells, while Flk-1
– cells required a minimum of
8 days to become cardiomyocytes. Using a similar
protocolonmESCsexpressingacardiacspecificalpha
myosin heavy chain (aMHC) promoter-driven GFP
produced approximately 10–18% GFP
+ cardiomyo-
cytesandoutperformedtheEBdifferentiationsystem
by2—3-foldintheproductionofcontractingcells.The
authors further showed that single Flk-1
+ cells, plated
onto OP9 feeder monolayers, gave rise to heteroge-
neous cell colonies composed of either endothelial
cells only (40% of colonies), a mixture of endothelial
and cardiac cells (43% of colonies) or only cardiac
cells (16% of colonies). This suggested that Flk-1
+
cells are able to develop into cardiomyocytes and
endothelial cells at the single cell level. A number of
cell surface markers were tested in conjunction with
Flk-1
+ to derive the progenitor sub-population capa-
ble of producing more homogeneous cardiac cell
clusters.Cellsthatco-expressedmarkerslikec-kitand
Sca-1ormesenchymalstemcellmarkerssuchasCD44
and CD90 with Flk-1 were examined for their differ-
entiation potential. Either no significant cardiomyo-
cyte differentiation was observed from double pos-
itive sub-populations, as in the case of Sca-1/Flk-1 and
CD90/Flk-1 cells, or marker expression was unable to
identify cardiac-restricted cells as in the case of (c-kit/
Flk-1). Interestingly, the unique combination of Flk-1
and CXCR4, a 7-transmembrane spanning G protein-
coupled receptor for chemokine CXC12 or SDF-1,
produced highly enriched cardiomyocyte colonies
which ceased to express either marker upon differ-
entiation. CXCR4 is expressed in splanchnopleuric
mesoderm and mesenchymal cells, but not in devel-
oping heart cells at E8.5 of mouse development. Flk-1
and CXCR4 were expressed in immature cells that
retained cardiogenic potential at the single cell level
but were lost in differentiated cardiac cells (Fig. 1)
[94].
Aside from mESC cardiac differentiation, which
appears to highlight differences between temporally
distinct cell subpopulations with or without Flk-1
expression, a range of somatic cells such as bone
marrow cells and more recently CPCs and CSCs from
cardiac tissues have also been highlighted as a
potentialsourceofcardiomyocyteswithimmunogeni-
cally distinct cell phenotypes [95]. These include Lin
–
c-kit
+ CD34
– CD45
—cells, which were shown to be
self-renewing, clonogenic, able to produce cardio-
myocytes,smooth muscle cells and endothelial cells in
vitroandtocontributetoregenerationoftheinfarcted
myocardium in animal models. In culture, these cells
have some  embryonic  cell features, including a high
nuclear-to-cytoplasmic ratio and active proliferation,
and they express some cardiac transcription factors. It
is unclear whether CSCs selected as the Lin
- c-kit
+
fraction originate from resident cells established
during heart formation or derive from as yet unde-
fined, circulating bone marrow cells [96]. Other cells
include the Sca1
+ CD31
+ c-kit
- adult myocardial
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after injection into a mouse cardiac infarction model
[97]. Messina and co-workers [98] reported the
formation of cardiospheres from human and mouse
heart cells that expressed Sca-1, c-kit, FLK1, CD31
and connexin 43, and this subpopulation appeared to
contribute to cardiac repair in infarcted mouse hearts.
Also  side population  cells, identified as Sca1
+ CD31
–
and possessing the ability to efflux Hoechst 33342,
have been reported to differentiate into cardiomyo-
cytesinvitro,andbeself-renewingandclonogenic[99,
100]. Another CD31
- population, the mESC-derived
FLk1
+ CD31
- VE-cadherin
- cells can form precursors
of the cardiac, endothelial as well as hematopoietic
lineages [101]. Other markers that were shown to be
highly enriched during early cardiac differentiation of
mouse P19 EC cells include pleiotrophin and podo-
calyxin, surface molecules which could be used to
select putative cardiogenic precursors [102].
Recent studies have shown progress in producing
HESC derived hematopoietic precursors in EBs or by
co-culture with the OP9 stromal cells [103–106]. By
comparison,reportsshowingdifferentiationofhESCs
towards the cardiogenic lineage are limited and show
variable efficiencies [5, 6].
UsingtheEND-2/HESCco-culturemethoddescribed
earlier, the appearance of beating structures was
shown to be substantially improved (by 24-fold) by
omission of fetal calf serum from the culture medium,
suggesting that calf serum may contain inhibitory
factors. An additional 40% increase in the number of
beatingareaswasobservedinthepresenceofascorbic
acid [107], thought to act as a free-radical scavenger,
as previously shown in mESCs.
Althoughthisrepresentsanefficientplatformtostudy
mesodermal differentiation of HESCs, a heteroge-
neous mixture of cells likely in different stages of
mesodermal commitment always results. With the
potential of applying specialized cells to reverse heart
disease, the task at hand is to exploit the current
differentiationplatformandtoisolateHESC-derived,
lineage-restricted precursors as shown for mESCs.
Thiscouldalsobeapproachedbyselectingspecificcell
subpopulations from the above culture system target-
ing specific cell surface markers which identify
precursor cells with cardiogenic potential. Microarray
analysis conducted on mesodermal cell progeny
obtained from END-2/HESC co-culture has shown
the induction of early embryonic genes involved in
mesoderm specification, like Brachyury T [75], and
indicates the presence of mesodermal precursor cell
subpopulations like those found in differentiating
mESCs. Hence, flow cytometric sorting (FACS) and/
or magnetic assisted cell separation (MACS) of
differentiating HESCs based on immunogenic pro-
files of cells found in differentiating mouse ESCs
offers the exciting prospect of identifying ESC-
derived cardiac precursor cells for selected expansion
and production upscale in culture. The purification of
these cells currently aims to generate more defined
approaches to study cardiac differentiation from
HESCs.
Conclusions and perspectives
It is clear that ESCs from both mouse and humans
differentiate towards cardiomyocytes that appropri-
ately respond to different pharmacologic stimuli, and
this infers functional expression of many of the
components required for excitation coupling. How-
ever, while maturation of HESC-CMs does occur
during prolonged culture, currently these cells fail to
attain the characteristic of adult cardiomyocytes. This
is likely to benefit attempts to use them for trans-
plantation. However, it will be important to assess
novel methods to stimulate maturation so in vitro
produced cardiomyocytes with embryonic or adult
characteristics are at the disposal of the scientific,
clinicalandpharmacologicalcommunity,asthiswould
be potentially useful in drug discovery and testing. In
addition,itmightbepossibletouseHESCstodevelop
in vitro models for studying specific genetic cardiac
diseases, such as channelopathies where specific ion
channel mutations may cause fatal arrythmias in
asymptotic carriers or to use them to identify the
function of genes associated with congenital heart
defects. HESCs and mESCs recapitulate the differ-
entiation of cardiac cells in the development of
humans and mice respectively, both in terms of gene
and protein expression as well as physiological
function. They thus provide a unique opportunity to
study heart development at stages where, at least in
humans, the heart is not accessible. In turn, this may
allow functional analysis of developmental genes in
vitro which may provide new clues into the genetic
basis of congenital heart defects in humans. Gene
sequencing technology is now so advanced and rapid
that it is little problem to interrogate several hundred
genomes in a short time for mutations in selected
genes. This may yield new screens for prenatal genetic
diagnosis in humans and prevent the birth of children
with congenital heart defects.
In terms of transplantation, it is also important to be
aware that whilst introduction of ectopic cardiac cells
inmicemightnotcausearrythmiasbecauseofthehigh
heart rate and adaptive capacity of the mouse heart,
thismaynotbethecaseinhumans.Transplantationof
skeletal myoblasts in patients has already caused
serious clinical complications [108, 109] because of
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More recently, transplantation of HESC-derived
cardiomyocytes into the hearts of pigs was described
[110]. Since pig heart physiology is more reminiscent
of human heart than rodents, the observation of
ectopic pacemaker-like activity from the transplanted
cells cautions against premature clinical application.
There are few proven sources of bone fide cardio-
myocytes in humans, but to date HESC-derived
cardiomyocytes and cardiac progenitor cells appear
to be retaining a status of clinical potential.
From an optimistic perspective, the development of
techniques for somatic cell reprogramming, perhaps
cloning, to derive stem cells from a patient s own
tissue may ultimately eliminate the use of immuno-
suppressive therapy in cell transplantation. The use of
HESC-derived cardiomyocytes for transplantation,
however, ultimately requires that the population be
devoid of non-cardiac cells to obtain optimal engraft-
ment and shows no evidence of contamination with
undifferentiatedstemcellsthat couldcauseteratomas
in vivo. From a societal stance, ischemic heart disease
and related pathologies are the most prevalent con-
sequences of mortality in the Western world. While
pharmacological therapy for patients improves car-
diac function, survival and quality of life, the natural
course of the disease cannot be halted, and gradual
progress towards severely impaired cardiac function
and death is generally inevitable. If it were possible to
reconstitute the heart by replacing poorly contracting
cells and scarred, post-ischemic tissue with functional
HESC-derived precursors to remodel the myocardi-
um, these problems could be circumvented.
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